Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIA-N2”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Large-scale testing (Phase 3)UnknownNCT01405079
What this trial is testing

Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation

Who this might be right for
Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 222
Large-scale testing (Phase 3)Ended earlyNCT02974426
What this trial is testing

To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IIIARadiotherapy
Shanghai Chest Hospital 132
Testing effectiveness (Phase 2)Study completedNCT02994576
What this trial is testing

Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 60
Testing effectiveness (Phase 2)UnknownNCT00616499
What this trial is testing

Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Yonsei University 35
Testing effectiveness (Phase 2)Study completedNCT01130753
What this trial is testing

Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer

Who this might be right for
Lung NeoplasmsErlotinibNeoadjuvant Therapy
Samsung Medical Center 43
Large-scale testing (Phase 3)Ended earlyNCT03447769
What this trial is testing

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 1,382
Large-scale testing (Phase 3)UnknownNCT00273494
What this trial is testing

Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2

Who this might be right for
Non-Small Cell Lung Cancer
Rigshospitalet, Denmark 406
Testing effectiveness (Phase 2)Active Not RecruitingNCT05894889
What this trial is testing

Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC

Who this might be right for
Stage IIIB(N2) Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung Cancer+1 more
Peking University 70
Testing effectiveness (Phase 2)UnknownNCT04455594
What this trial is testing

Almonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLC

Who this might be right for
Non-Small Cell Lung Cancer Stage IIIA
The First Affiliated Hospital of Guangzhou Medical University 168
Testing effectiveness (Phase 2)Ended earlyNCT04422392
What this trial is testing

Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 93
Testing effectiveness (Phase 2)UnknownNCT03053856
What this trial is testing

Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
Samsung Medical Center 37
Testing effectiveness (Phase 2)Study completedNCT00003231
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Swiss Cancer Institute 40
Testing effectiveness (Phase 2)Ended earlyNCT02276560
What this trial is testing

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Who this might be right for
Stage IIIA Non-Small Cell Lung Cancer
UNC Lineberger Comprehensive Cancer Center 1
Not applicableUnknownNCT03381430
What this trial is testing

Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR

Who this might be right for
Lung Cancer
Qilu Pharmaceutical Co., Ltd. 50
Not applicableStudy completedNCT02966769
What this trial is testing

N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation

Who this might be right for
Non-small-Cell Lung CarcinomaSurgeryStage IIIA-N2+2 more
Grupo de Investigación Clínica en Oncología Radioterapia 294
Early research (Phase 1)Study completedNCT00005065
What this trial is testing

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)Study completedNCT00880971
What this trial is testing

Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer

Who this might be right for
Thoracic NeoplasmsNon-small Cell Lung Cancer
Chinese Academy of Medical Sciences 394
Large-scale testing (Phase 3)UnknownNCT00410683
What this trial is testing

Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery

Who this might be right for
Non-small Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 500
Large-scale testing (Phase 3)Study completedNCT00775385
What this trial is testing

TAilored Post-Surgical Therapy in Early Stage NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 152
Not applicableTemporarily Not AvailableNCT01297101
What this trial is testing

Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Chest Hospital
Next Page